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Summary
 
The signals controlling the checkpoints of dendritic cells (DC) maturation and the correlation
between phenotypical and functional maturational stages were investigated in a defined model
system of growth factor–dependent immature mouse DC. Three sequential stages of DC mat-
uration (immature, mature, and apoptotic) were defined and characterized. Immature DC
(stage 1) had low expression of costimulatory molecules, highly organized cytoskeleton, focal
adhesion plaques, and slow motility; accordingly, they were very efficient in antigen uptake
and processing of soluble proteins. Further, at this stage most of major histocompatibility com-
plex class II molecules were within cytoplasmic compartments consistent with a poor allostim-
ulatory capacity. Bacteria or cytokines were very efficient in inducing progression from stage 1
towards stage 2 (mature). Morphological changes were observed by confocal analysis including
depolymerization of F-actin and loss of vinculin containing adhesive structures which correlates
with acquisition of high motility. Antigen uptake and presentation of native protein antigen
was reduced. In contrast, presentation of immunogenic peptides and allostimulatory activity
became very efficient and secretion of IL-12 p75 was detectable after antigen presentation. This
functional DC maturation ended by apoptotic cell death, and no reversion to the immature
phenotype was observed.
 
D
 
endritic cells (DC)
 
1
 
 comprise a family of professional
APC responsible for the activation of naive T cells and
the generation of primary T cell responses (1). To fully
perform these functions, DC residing in non-lymphoid tis-
sues need to be activated and to initiate a differentiation
process. This maturation of DC is characterized by pro-
found changes in MHC class II distribution, antigen-pro-
cessing capacity (2), expression of costimulatory molecules
(3) and a marked rearrangement of adhesion molecules that
is likely to allow DC migration to lymphoid organs (4). DC
maturation should be critically controlled by microenvi-
ronmental signals. However, limited knowledge exists about
the factors and the mechanisms regulating DC cell cycle,
life span, and functional activity. Cytokines secreted in a
paracrine (e.g., GM-CSF, TNF
 
a
 
) or autocrine (TNF
 
a
 
,
IL-1
 
b
 
) fashion control DC movements (4), survival (5),
and APC activity (6, 7), but the fine biochemical mecha-
nisms underlying these effects are not known. Once DC
have interacted with T cells, they complete the differentia-
tion process, which is believed to terminate by apoptosis.
Several groups have succeeded in generating large num-
bers of functional DC/Langerhans cells (LC) in both the
murine or the human system by treating DC precursors
with GM-CSF alone or in combination with other growth
factors (8–13). However, such DC could be propagated
only for limited time periods, i.e., up to 3 mo. More re-
cently, growth factor-dependent long-term DC lines from
mouse fetal or newborn skin have been established (14,
15). Nevertheless, although these lines possess the proper-
ties of DC precursors and maintain an immature phenotype
they cannot be induced to mature in vitro (14, 15).
Here we present evidence that MHC class II–positive
growth factor–dependent immature DC, derived from adult
mice spleen, can be driven in vitro to proliferate over more
than one year of continuous culture. Proliferation and sur-
vival of such immature cells are strictly dependent upon
the presence of exogenous GM-CSF and fibroblast-derived
growth factors. Long-term DC preserve an immature phe-
notype but various activating signals, such as living bacteria
 
1
 
Abbreviations used in this paper:
 
 DC, dendritic cells; LC, Langerhans cells;
SN, supernatant.
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or cytokines, promote full maturation. During this process,
class II molecules are exported at the cell surface, adhesion/
costimulatory molecules are upregulated, the actin-based
cytoskeleton is rearranged, and cell motility is increased.
Furthermore, only matured cells are able to activate anti-
gen-specific T cells and to produce IL-12 p75, a key cyto-
kine skewing the response towards a Th1 polarization.
Using this novel in vitro differentiation system, kinetic
stages of DC maturation and apoptotic cell death could be
established. On the basis of the results of this study and pre-
vious data from the literature, a model of DC maturation
checkpoints and sequential events is proposed.
 
Materials and Methods
 
Animals.
 
Mice were purchased from Charles River Laborato-
ries (Calco, Como, Italy). To obtain DC cultures female C57BL/6
mice were used at 6–10 wk of age. For the MLR assay, female
BALB/C mice at 2–4 mo of age were used as source of lymph-
node cells.
 
Culture Media.
 
Culture medium was IMDM (Sigma Chem.
Co., St. Louis, MO) containing 10% heat-inactivated FBS (Hy-
clone, Logan, Utah), 100 IU/ml penicillin, 100 
 
m
 
g/ml strepto-
mycin, 2 mM 
 
L
 
-glutamine (all from Sigma), and 50 
 
m
 
M 2-
 
b
 
ME
(complete IMDM). Fibroblast supernatant (SN) from NIH/3T3
cells was collected from confluent cultures and filtered (0.2 
 
m
 
;
Corning Glass Works, Corning, NY).
 
Cytokines and Bacteria.
 
Recombinant murine GM-CSF was
purchased from PharMingen (San Diego, CA). Recombinant hu-
man IL-2 was from R&D Systems (Wiesbaden, Germany). Mu-
rine rTNF
 
a
 
 (Genentech Inc., San Francisco, CA) was used at 100
U/ml. Murine rIL-1
 
b
 
 and rIL-6 were purchased from Genzyme
(Cambridge, MA) and used at 10 ng/ml. 
 
Escherichia coli
 
 (Gram
 
2
 
)
and 
 
S. aureus
 
 (Gram
 
1
 
) bacteria were kindly provided by G. Pozzi
and D. Medaglini (University of Siena, Italy). In experiments of
DC stimulation, bacteria: DC ratio was 1:1. DC cells were cul-
tured with living bacteria for 18 h before analysis. LPS (
 
E. coli
 
026:B6 from Sigma) was used at 1 
 
m
 
g/ml.
 
Generation of DC Cultures.
 
Spleens from 6–10-wk-old female
C57BL/6 mice were used. Single cell suspensions were obtained
by gentle teasing with forceps and filtered with a cell strainer.
Erythrocytes were lysed by treatment with ammonium chloride.
Remaining unfractionated cell populations were plated at a den-
sity of 5 
 
3
 
 10
 
5
 
 cells/ml in suspension culture Petri dishes (Corn-
ing Glass Works, Corning, NY). Culture medium for generation
and expansion of DC was complete IMDM supplemented with
30% NIH/3T3 SN containing 10–20 ng/ml mouse rGM-CSF
(we refer to this conditioned medium as R1 medium). Cultures
were fed with fresh R1 medium every 3–4 d. First passages of
DC-enriched cultures were performed after 
 
z
 
2 wk. Both sus-
pended and weakly adherent cells were propagated. Clusters of
adherent cells with dendritic morphology were detached using
PBS with 3 mM EDTA. The remaining strongly adherent cells
were discarded. After 3 mo of culture, cells could be passaged ev-
ery week. Experiments were performed with cells continuously
cultured for more than 12 mo. This homogeneous, growth fac-
tor–dependent DC population, is referred to as D1 cells.
In experiments using rTNF
 
a
 
, culture medium was changed
before the experiment and fresh rTNF
 
a
 
 (100 U/ml) was added
every 24 h. Similarly, rM-CSF and rGM-CSF were used at a
concentration of 20 ng/ml.
 
Antibodies.
 
Biotin-labeled N418 specific for CD11c was pre-
pared as described (16). Hybridoma 2.4G2 (rat anti–mouse
Fc
 
g
 
II/III receptor, CD32) was a kind gift from B. Kyewski
(DKFZ, Heidelberg, Germany). Biotinylated anti-F4/80 was pur-
chased from Serotec (Oxford, UK). The following biotinylated
mAbs were from PharMingen: H-2K
 
b
 
 (AF6-88.5), H-2D
 
b
 
 (28-
14-8), CD80/ B7.1 (1G10), CD11a/LFA-1 (2D7), CD11b/Mac-1
(M1/70), CD54/ICAM-1 (3E2), CD45 (M1/9.3), CD117/c-kit
(3C1) B220 (RA3-6B2), and CD4 (RM4-5) FITC-conjugate
HM40-3 specific for CD40 and rat IgM J11d (heat-stable antigen
[HSA]) (both from PharMingen). Anti–class II (I-A
 
b
 
,
 
d
 
) hybri-
doma (34-5-3S) was purchased from the American Tissue Cul-
ture Collection (ATCC, Rockville, MD) and biotinylated. PE-
conjugated 2G9 (PharMingen) was used for staining I-A/Ed.
FITC-coupled GL1 (PharMingen) was used for staining of
CD86/B7.2. Rabbit polyclonal antibodies anti-c-fms/CSF1R
(C20) and anti-FAS-L (Q20) were from Santa Cruz Biotechnol-
ogy; hamster polyclonal anti-FAS antibody was from Pharmin-
gen. PE-conjugated and FITC-conjugated donkey anti–mouse and
Texas red-conjugated donkey anti–rabbit Ig were from Jackson
ImmunoResearch (West Grove, PA). PE-streptavidin, FITC-
conjugated extravidin, and FITC-goat anti–rabbit IgG were pur-
chased from Sigma. Mouse adsorbed goat anti–rat Ig FITC and
goat anti–hamster IgG-PE were from Southern Biotechnology
(Birmingham, AL). Mouse anti–rat IgM FITC and isotype-matched
control antibodies were from PharMingen. Anti-vinculin and anti-
tubulin mAbs and rodhamin-conjugated phalloidin were a gener-
ous gift of P. Chavrier (Centre d’Immunologie de Marseille Luminy
[CIML], Marseille, France) and were used at the final concentra-
tion of 1 
 
m
 
g/ml. Anti-murine H2-M
 
b
 
 polyclonal rabbit antibody
was kindly provided by N. Barois (CIML). Before labeling exper-
iments, FcR blocking was performed by incubating cells with 5%
normal mouse serum or 2.4G2 (anti-CD32) supernatant.
 
Cell Surface Phenotype.
 
Both suspended and adherent cell pop-
ulations were harvested and analyzed. Adherent cells were de-
tached with PBS buffer containing 3 mM EDTA (3 min 37
 
8
 
C).
Staining was performed according to standard immunofluores-
cence techniques. Aliquots of cells (1.5 
 
3
 
 10
 
5
 
/sample) were pre-
incubated for 30 min on ice with undiluted 2.4G2 SN to prevent
binding to Fc
 
g
 
RII/III. Cells were then exposed to FITC-cou-
pled GL1, FITC-coupled HM40-3, PE-conjugated 2G9, bio-
tinylated mAbs (all used at 10–20 
 
m
 
g/ml), or J11D culture SN for
30 min on ice. Appropriately diluted FITC-streptavidin, PE-
streptavidin, or FITC-conjugated mouse anti–rat IgM, respec-
tively, were used to detect binding of biotinylated mAbs. When
2.4G2 hybridoma culture SN were used as first step reagent,
binding of antibody was detected by FITC-coupled goat anti–rat
Ig. After every incubation step, samples were washed with PBS
containing 0.1% sodium azide and 2% FCS. Flow cytometry
analysis was performed with a FACScan
 
Ò
 
 (Lysis I software; Bec-
ton Dickinson). For sorting experiments, sodium azide contain-
ing antibodies were dialyzed against IMDM and sterile filtered
before use. Cell sorting was performed with a FACS
 
Ò
 
 Vantage
(Becton Dickinson) using the Lysis I program. Cells were gated
for size and side scatter to exclude dead cells and debris.
 
Detection of Apoptosis.
 
Cells in log phase of growth were thor-
oughly washed out from GM-CSF and fibroblast-conditioned
culture medium. 6 
 
3
 
 10
 
5
 
 cells were replated in 5 ml of medium
without cytokines and SN or, for control stainings, in fully sup-
plemented culture medium. At different time points (24–72 h) af-
ter growth factor deprivation, cytospins were prepared and slides
fixed in acetone. To detect cells containing DNA fragments, the
TUNEL (TdT-mediated dUTP nick-end labeling) method was 
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employed with the modifications suggested by the supplier (DIG
Oligonucleotide 3
 
9
 
-End Labeling Kit; Boehringer Mannheim,
Germany). Slides were rinsed three times in PBS and kept for 30 min
at room temperature protected from light in humid atmosphere
with 20 
 
m
 
g/ml rhodamine-labeled sheep anti-digoxigenin antibody
Fab fragments (Boehringer Mannheim). Three washing steps in
PBS followed to eliminate unbound antibody. Stained samples
were mounted in Fluoromount G (Southern Biotechnology).
 
Intracellular Immunofluorescence.
 
To visualize the intracellular
distribution of class II molecules and of cytoskeleton elements, 48 h
TNF
 
a
 
-treated D1 cells were seeded on polylysin-coated cover-
slips for 20 min at room temperature. After adhesion, cells were
washed and incubated for 20 min at 37
 
8
 
C in culture medium.
Control cells were incubated over night on glass coverslips. Fixa-
tion was performed for 15 min at room temperature in 4% (wt/
vol) paraformaldehyde in PBS. In selected experiments, to pre-
serve the microtubules organization, cells were fixed with 3%
paraformaldehyde, 0.3% glutaraldehyde, and incubated for 5 min
at room temperature in a NaBO4 buffer (100 mM, pH 7.4) be-
fore permeabilization. Fixed cells were washed three times in PBS
containing 10 mM glycine, 0.1 mM MgCl
 
2
 
, and 0.1 mM CaCl
 
2
 
,
permeabilized for 30 min at room temperature with 0.5% (wt/
vol) saponin, in PBS/0.2% BSA. For class II compartment char-
acterization, coverlips were incubated for 30 min at room tem-
perature with 5 
 
m
 
g/ml mouse anti–I-A
 
b,d
 
 class II (34.5.3S) and 5
 
m
 
g/ml rabbit anti-H2-M
 
b
 
 Abs, washed and then incubated for
30 min at room temperature with 10 
 
m
 
g/ml FITC-conjugated
donkey anti–mouse and 10 
 
m
 
g/ml Texas red-conjugated donkey
anti–rabbit Abs.
To visualize the cytoskeleton organization coverslips were
incubated for 30 min at room temperature with anti-vinculin
(1 
 
m
 
g/ml) or anti-tubulin (1 
 
m
 
g/ml) mAbs, washed, and then in-
cubated for additional 30 min at room temperature with 10 
 
m
 
g/ml
FITC-conjugated donkey anti–mouse antibodies in the presence
or absence of rhodamine-labeled phalloidin to visualize F-actin. Be-
fore mounting in Moviol (Sigma), samples were washed three
times in staining buffer and once in distilled water. Cell morphology
was analyzed by confocal microscopy using reflection interference
contrast. Confocal laser scanning microscopy was performed us-
ing a Leica TCS 4D (Leica Lasertechnik, Heidelberg, Germany)
as described (17, 18). A focal series of four horizontal or vertical
planes of section spaced by 0.75 mm were monitored simulta-
neously for fluorescein and Texas red/rhodamine, using the 488
and 568 nm laser lines of an argon-krypton, a double dichroic
mirror for the excitation beam, a FITC band pass 520–560-nm
barrier filter and a long pass barrier filter above 580 nm for Texas
red/rhodamine detection, using green-sensitive and red-sensitive
photomultipliers, respectively. The FITC/Texas red 8 bits-encoded
1024 
 
3 
 
1024 pixel images from the same plane of section were
superimposed and visualized with a green/red pseudocolorscale
on a true color display monitor before printing using a Codonics
NP-1600 dye-sublimation color printer (Codonics, Middleburg
Heights, OH).
 
Time-Lapse Videomicroscopy.
 
D1 cells were continuously re-
corded for 16 h with a Zeiss Axiovert microscope equipped with
a small incubator (37
 
8
 
C) and video camera, through the courtesy
of Fabrizio Manca and Daniele Severino (University of Genova,
Italy). TNF
 
a
 
 (100 U/ml) was added to the D1 culture after the
first 2 h of recording.
 
Endocytosis.
 
Ovalbumin (OVA) and Dextran (40,000 dalton)
were purchased from Sigma and conjugated with FITC, as de-
scribed (19). Cells were grown in culture medium in the presence
or absence of 100 U/ml mrTNF-
 
a
 
. After 48 h, cells were incu-
bated at 37
 
8
 
C or at 0
 
8
 
C for 1 h with 0.1–1 mg/ml FITC-OVA,
or FITC-Dextran (FITC-DX). Uptake was stopped by adding
ice-cold FACS
 
Ò
 
 buffer followed by three washes in ice-cold PBS
with 5% BSA and 0.02% sodium azide. After staining with the
anti–class II mAb (30 min on ice) cells were analyzed by flow cy-
tometry using a FACScan
 
Ò
 
 (Becton-Dickinson, San Jose, CA).
 
Mixed Leukocyte Reaction Assay.
 
Primary allogeneic MLR was
set up with I-A
 
bright
 
 and I-A
 
int
 
 sorted DC as stimulators one day
after FACS
 
Ò
 
 sorting. Stimulator cells were treated with mitomy-
cin C (50 
 
m
 
g/ml, 20 min at 37
 
8
 
C; Sigma) and cocultured with 2 
 
3
 
10
 
5
 
 BALB/c lymphnode cells/well in 200 
 
m
 
l of complete IMDM.
Cultures were pulsed on day 3 with 1 
 
m
 
Ci/well of [
 
3
 
H]thymidine
(specific activity 2.0 Ci/mmol; Amersham, Amersham Place, UK).
Incorporation of [
 
3
 
H]thymidine was measured 18 h later with a
liquid scintillation counter (MicroBeta Plus; Wallac, Turku, Fin-
land). Each point in the graphs represents the mean cpm from
triplicate cultures.
 
Antigen Presentation Assay.
 
TNF
 
a
 
-treated (100 U/ml) or un-
treated D1 (1 
 
3
 
 10
 
4
 
 cells/well) were seeded in flat-bottomed mi-
crotiter plates (Corning) pulsed with OVA protein (grade III;
Sigma) or peptide 327-339 (kindly synthesized by R. Longhi, CNR,
Milan, Italy) and cultured together with the T cell hybridoma
BO97.10 (5 
 
3
 
 10
 
4
 
 cells) specific for OVA/A
 
b
 
 (20) in complete
IMDM in a final volume of 200 
 
m
 
l/well. Plates were incubated
for 24 h at 37
 
8
 
C with 5% CO
 
2
 
. Aliquots of supernatants were
harvested and frozen before measuring IL-2 content. CTLL-2
were grown in 100 U/ml rIL-2 and extensively washed before
being added to thawed supernatants. CTLL-2 cells (10
 
4
 
 cells/
well) were incubated for 24 h with 50 
 
m
 
l of the supernatants in a
150 
 
m
 
l final vol/well and pulsed with 1 
 
m
 
Ci/well of [
 
3
 
H]thymi-
dine (specific activity 5.0 Ci/mmol; Amersham) for additional 6 h.
Incorporation of [
 
3
 
H]thymidine by CTLL-2 cells was measured
by liquid scintillation counting. Each point in the graphs repre-
sents the mean cpm from triplicate cultures.
 
IL-12 Production.
 
IL-12 p75 production by D1 cells was mea-
sured following antigen presentation. In brief, TNF
 
a-treated
(100 U/ml) or untreated D1 cells (1 3 104 cells/well) were
seeded in flat-bottomed microtiter plates, pulsed with OVA pro-
tein (grade III; Sigma) or peptide 327-339 and cultured together
with 5 3 104 BO97.10 T cell hybridoma specific for OVA/Ab in
complete IMDM in a final volume of 200 ml/well. After 24 h
culture at 37°C in 5% CO2 supernatants were tested for IL-12
p75 content. Polyvinyl microtiter plates (Falcon 3012) were
coated with 100 ml of the rat anti–mouse IL-12 heterodimer 9A5
mAb, in carbonate buffer. After blocking, 50 ml/well of samples
were diluted in test solution (PBS containing 5% FCS and 1 g/l
phenol) and incubated together with 50 ml peroxidase-conju-
gated 5C3 mAb (rat anti–mouse IL-12 p40 subunit). Anti-IL-12
antibodies (21) were kindly provided by Dr. M.K. Gately (Hoff-
mann-La Roche Inc., Nutley, NJ). After overnight incubation at
4°C, bound peroxydase was detected by 3,39-5,59-tetramethyl-
benzidine (Fluka Chemical Co.), and adsorbance read at 450 nm
with an automated microplate ELISA reader (MR5000; Dyna-
tech). IL-12 p75 was quantified from two to three titration points
using standard curves generated by purified recombinant mouse
IL-12 and results expressed as cytokine concentration in pg/ml.
Detection limit was 10 pg/ml.
Results
Generation of Long-term Immature DC from Cultured Mouse
Spleen Cells. DC were derived from spleen cell suspen-320 Maturational Stages of Mouse Dendritic Cells
sions cultured in medium supplemented with fibroblast su-
pernatant, known to support the growth of skin DC (22),
together with GM-CSF, a cytokine essential for DC growth.
Typical adherent aggregates of DC with fine membrane
projections were visible at the periphery of the clusters on
day 10–12 and in the following days both cell clusters and
DC increased in number and size. The first passage was
performed around days 12–14 using EDTA treatment to
leave behind only the strongly adherent cells. After 10–12
wk, cultures consisted of single adherent cells with fine cy-
toplasmic protrusions, adherent cell clusters and cells grow-
ing in suspension, some of which had veiled morphology.
Cell growth could be continuously maintained (at least over
one year) but was strictly dependent on the presence in the
culture medium of GM-CSF and fibroblast supernatant
(R1 medium). Growth factor deprivation led to cell growth
arrest and cell death (Fig. 1). DNA fragments in apoptotic
cells were visualized by TUNEL staining, starting from
24–48 h after deprivation, with a number of viable cells de-
creasing to less than 10% after 1 wk (data not shown). After
6 mo of continuous growth this long-term bulk culture of
spleen DC was named D1. The method is highly repro-
ducible given that additional long-term growth factor–
dependent DC lines have been independently generated
using the same approach.
Figure 1. Growth curve of D1 cells in the presence of conditioned
medium (R1) or growth factors deprived (medium alone).
Figure 2. Surface markers of D1 bulk culture by
FACSÒ analysis. Filled histograms are showing
binding of specific antibodies, whereas isotype
matched control antibodies or secondary reagents
are represented by open histograms. Cell surface
phenotype was assessed with antibodies as indicated
in Materials and Methods. Before all labeling ex-
periments, FcR blocking was performed by incu-
bating cells with 5% normal mouse serum or anti
FcR (2.4G2) mAb.321 Winzler et al.
D1 Cells Preserve the Phenotype of Immature DC, and Can-
not Be Converted to Macrophages in Response to M-CSF.
Surface markers expressed in D1 cultures included CD11c
(N418), FcgII/III receptor (2.4G2), and F4/80; NLDC145
was expressed only in z10% of the cells (Fig. 2). The ma-
jority of the cells expressed moderate levels of membrane
class II molecules (I-Aint), but 20% of the cells expressed
high levels (I-Abright) of class II molecules. The same stain-
ing pattern, albeit at lower fluorescence intensity, was ob-
served for B7.2. Double-color flow cytometric analysis of
unstimulated cells showed that I-Abright cells were those ex-
pressing higher levels of B7.2 (Fig. 3). D1 were positive for
all class I antigens (H-2 K, D), and for the costimulatory
CD40 and B7.1 molecules (Fig. 2). Adhesion and homing
receptors such as CD11a (LFA-1), CD11b (Mac-1), CD54
(ICAM-1), and VLA-4 were highly expressed, as well as
the heat stable antigen (HSA/J11d). In contrast, granulo-
cytes, T and B cell markers were negative (Fig. 2), whereas
c-kit and Fas ligand were expressed, although at low levels.
Interestingly, the M-CSF receptor c-fms (CD115) was also
expressed but experiments aimed at converting the D1 cells
to a macrophage phenotype by adding rM-CSF in culture,
showed that substitution of rGM-CSF (or R1 supernatants)
with M-CSF (or M-CSF supplemented with fibroblast su-
pernatant) in the culture medium, reduced the D1 cell via-
Figure 3. Dot plot double-color FACSÒ analysis of MHC class II and
B7.2 molecules of D1 bulk culture.
Figure 4. Phenotypical maturation of D1 cells.
Surface markers by FACSÒ analysis after cytokine
or living bacteria treatment. MHC class II (I-A),
B7.2, CD40, and ICAM-1 molecules of D1 bulk
culture growing in R1 medium or in medium sup-
plemented with TNFa, LPS, IL-1b, or IL-6 (A) or
after treatment with living E. coli or S. aureus (B).322 Maturational Stages of Mouse Dendritic Cells
bility to 15%, in 3 d. Growth arrest was observed in the re-
maining viable cells, which survived only for a few weeks.
Altogether these results indicate that mouse spleen DC,
grown in the culture conditions listed above, preserve the
phenotype characteristic of immature DC.
Phenotypic Maturation of DC Can Be Induced by Microbes,
LPS or Cytokines such as TNFa and IL-1b, but not IL-6.
Floating cells with veils and dendrites were seen in unstim-
ulated cultures only at low frequency and most of the cells
appeared to be loosely adherent to the surface of the cul-
ture dish. When cells were treated daily with 100 U/ml
TNFa for 1–4 d, they detached from plastic surface, devel-
oped larger veils and longer dendrites, and formed large
floating cell aggregates (data not shown). These morpho-
logical changes were also easily observed by time-lapse
videomicroscopy (see below).
TNFa, LPS, IL-1b, and IL-6 were tested for their ability
to modulate the expression of markers involved in APC/T
cell interactions and differentially expressed in immature
versus mature DC. Cells were stimulated for 24 h with ei-
ther 100 U/ml TNFa, 1 mg/ml LPS or 10 ng/ml IL-1b,
stained, and then analyzed by flow cytometry. I-A, B7.2,
CD40, and ICAM-1 molecules were strongly upregulated
by all stimuli, whereas expression of the same surface mole-
cules did not change after treatment with 10 ng/ml IL-6
(Fig. 4 A).
Gram1  (S. aureus) and Gram2 ( E. coli) living bacteria
were also used to activate immature D1 cells. Both types of
bacteria induced upregulation of MHC class II, B7.2 and
CD40 molecules, whereas ICAM-1 was unchanged (Fig. 4 B).
Mature I-Abright DC Are Derived from Immature I-Aint Cells.
To ascertain whether the I-Abright cells were deriving from
the I-Aint cells, the two populations were FACSÒ-sorted
and then cultured again after sorting. Analysis of surface I-A
expression after 6 d of culture showed that previously
sorted I-Aint cells included again a small population of
I-Abright cells (data not shown). Because previous experi-
ments showed that LPS increased surface expression of I-A
molecules, culture medium was examined for traces of en-
dotoxin content as a possible explanation for this apparently
spontaneous in vitro maturation. Indeed, a very low amount
(z0.3 ng/ml) of endotoxin was detected in the standard
R1 culture medium, thus suggesting that the observed sponta-
neous DC maturation may be due to LPS.
Sorted I-Abright cells replated in culture displayed a mor-
phology similar to those treated with TNFa, including for-
mation of floating aggregates. However, I-Abright cells could
not be propagated in culture, and .90% of these sorted
cells could not be rescued after 6 d of culture. Neither ad-
dition of TNFa nor addition of the R1 supernatant im-
proved the viability of I-Abright sorted cells (data not shown).
This finding indicates that DC maturation is an irreversible
process and that when particular checkpoints are passed,
maturation can not be reverted. This is also suggested by
the impossibility to propagate long-term DC purified on
the basis of high MHC class II expression.
Redistribution of MHC Class II Molecules and Their Export
to the Cell Surface Membrane Correlates with DC Matura-
tion. Confocal microscopy after staining with anti-class II
mAbs revealed that unstimulated cells express high amounts
of class II molecules. However, consistent with the results
of FACSÒ analysis, most of them were not at the cell sur-
face but were contained in discrete intracellular vesicular
compartments (Fig. 5 a). A minor cell population, (z15%),
exhibited a more pronounced DC morphology and were
stained more strongly at the cell surface and less intracellu-
larly (not shown). To better define the characteristics of these
intracellular class II positive compartments, double staining
with anti-H2-Mb antibody was performed. Class II posi-
tive vesicles appear to colocalize with H2-Mb-positive ves-
icles in immature D1 cells (Fig. 5 a, yellow color due to the
superimposition of green class II–containing vesicles and
red H2-Mb-containing vesicles). These results indicate that
mature class II molecules, exported from the trans-Golgi
network, are mostly located in a compartment similar to
the MIIC, and to the prelysosomal compartments defined
in B cells. In contrast, maturation of D1 cells with TNFa,
induced a redistribution of class II molecules at the cell sur-
Figure 5. Redistribution of
MHC class II molecules during
maturation. Double-color con-
focal laser scanning microscopy
analysis of class II–containing
compartments in immature (a)
and mature (b) D1 cells. Class II–
positive (green) and H2-Mb-pos-
itive (red) vesicles are mostly
colocalized (yellow) in untreated
D1 cells (a). Treatment of the
cells with TNFa induces the re-
distribution of class II molecules
from the cytoplasm to the cell
surface (b) and no colocalization
between class II (green) and H2-
Mb (red) containing vesicles can
be observed.323 Winzler et al.
Figure 6. Cytoskeleton modifications in
D1 cells after TNFa treatment. Immature (a)
and mature (b) D1 cells morphology was ana-
lyzed by confocal microscopy using reflection
interference contrast which gives the best vi-
sualization of the cell interface zone when at-
tached to a glass support (37). Confocal laser
scanning microscopy of D1 cells stained with
anti-vinculin (c and d), phalloidin (e and f),
and anti-tubulin (g and h) was also performed.
Immature D1 cells (a, c, e, and g) appear to be
adherent (a) and characterized by: vinculin
containing adhesive structures (a and c, ar-
rows), subcortical actin aggregates (e), and
highly organized tubulin (g). D1 treatment
with TNFa ( b ,  d,  f, and h) clearly induces
morphological modification (b). Mature D1
cells lose adherence (b), vinculin (d), and sub-
cortical actin organization ( f ). No differences
in the amount of vinculin protein are detect-
able by Western blot analysis (d, inset). Micro-
tubules are only partially affected by TNFa
treatment (h).324 Maturational Stages of Mouse Dendritic Cells
face. Although intracellular class II staining was still ob-
served no colocalization with H2-Mb molecules was visu-
alized (Fig. 5 b, green class II–containing vesicles and red
H2-Mb-containing vesicles do not colocalize). This result
suggests that DC maturation involves a redistribution of
MHC class II molecules: fully mature D1 cells have class II
molecules expressed mostly at the cell surface and only par-
tially in intracellular compartments.
Rearrangement of Microfilaments and of Microtubules Corre-
lates with DC Functional Maturation. Cell migration requires a
coordinate series of events that include a sequential rear-
rangement of both surface adhesion molecules and of the
actin-based cytoskeleton. Immature D1 cells are character-
ized by numerous membrane expansions that terminate in
adhesive structures displayed in the panel by black arrows
(Fig. 6 a). Highly organized vinculin can be visualized in
the adhesive structures (Fig. 6 c, arrows). These structures are
also characterized by the simultaneous staining for F-actin
and vinculin (compare c with e). Unstimulated D1 cells
shown subcortical actin aggregates, as visualized by phalloi-
din staining (Fig. 6 e). After TNFa treatment, D1 cells un-
dergo a profound change in shape and lose both the large
membrane expansions and adhesiveness (Fig. 6 b). Vinculin
is disassembled (Fig. 6 d) and polymerized F-actin is no
longer detectable (Fig. 6 f). However, equal levels of vin-
culin protein were detected in both TNFa treated and un-
treated D1 cells, as shown by western blot analysis (Fig. 6 d,
inset). In contrast to the disassembly of the actin filaments
organization, microtubules are only partially affected by
TNFa treatment (Fig. 6, g and h). The centriolar organiza-
tion of microtubules appear to be more prominent after
TNFa treatment.
The Ability of DC to Become Highly Mobile Correlates with
their Functional Maturation. Migratory properties are essen-
tial to DC function and can be followed in vitro by time-
lapse videomicroscopy. D1 cells, continuously observed for
2 h were moderately motile, but after treatment with TNFa
they acquired a veiled morphology and became highly mo-
bile within 1–2 h. On the average TNFa-treated, mature
D1 cells migrated z30–40 m within 10 min (data not
shown) with a broad range of individual mean velocities
(2–5 m/min). The migration paths were characterized by
directional motility with changes in directions as if there
was an ongoing scanning process of the surrounding mi-
croenvironment.
Very few cell divisions were observed during the 14-h
experimental period, whereas frequent cell divisions were
seen in the untreated D1 cells. This functional maturation
process is likely to be irreversible at the single-cell level,
but as the D1 population is heterogeneous (containing pro-
genitors, immature and mature DC) self-regeneration oc-
curs continuously.
Immature DC Acquire Antigens through Fluid Phase and Re-
ceptor-mediated Endocytosis with Higher Efficiency as Compared
to Mature DC. Unstimulated D1 cultures were very effi-
cient in fluid phase and receptor-mediated antigen uptake,
a property largely abolished when the experiments were per-
formed at 08C. Using double-color FACSÒ analysis, the up-
take at 378C of FITC-OVA and FITC-DX was analyzed in
the MHC class IIint and in the MHC class IIbright D1 cell sub-
populations. The highest uptake of FITC-OVA and FITC-
DX was associated with MHC class II int cells (Fig. 7). In
contrast, the MHC class II bright D1 subpopulation was less
efficient in FITC-OVA and FITC-DX uptake, thus indi-
cating that macropinocytosis and receptor-mediated en-
docytosis are highly reduced in mature DC.
I-Abright DC Are Superior to I-Aint Cells as Stimulators in the
Primary MLR but Less Efficient in the Presentation of Native
Exogenous Protein Antigen. 1 d after sorting, I-Abright and
I-Aint cells were used as stimulators of unprimed BALB/c
lymphnode T lymphocytes. I-Abright cells resulted much
more potent activators of allogeneic T cells as compared to
I-Aint cells (Fig. 8 a), in agreement with the notion that ma-
ture DC acquire a stronger stimulatory activity. However
the situation may be different for nominal class II–restricted
protein antigens. Immature murine DC were in fact re-
ported to present native protein antigens better than short-
term cultured DC (19). To address this issue, I-Abright and
I-Aint sorted cells were compared for their capacity to pro-
cess and present native OVA or OVA peptides to the spe-
cific T hybridoma BO97.10. Sorted I-Aint cells were more
efficient in the presentation of native OVA whereas both
I-Abright and I-Aint cells were very efficient in the presenta-
tion of the peptide to the same hybridoma (data not shown).
Figure 7. Antigen uptake (FITC-OVA and FITC-DX) by D1 bulk
population in the presence or absence of TNFa was analyzed by double-
color FACSÒ analysis. The D1 cells that better internalize soluble antigens
at 37°C expressed comparatively low levels of MHC class II molecules,
whereas class IIbright were less efficient in both FITC-OVA and FITC-DX
uptake. Incubation of the cells with TNFa reduced the protein uptake of
the immature D1 subpopulation and had no effects on the mature D1
subpopulation.325 Winzler et al.
To test whether TNFa regulates antigen presentation,
D1 cells were employed either untreated or after pretreatment
with TNFa for 24 h, or for 7 d. The presentation of OVA
protein was reduced (about one log) by pretreatment with
TNFa, especially in the presence of lower antigen concen-
trations (Fig. 8 b). This result is likely to reflect the different
processing abilities of immature versus mature DC popula-
tions. In contrast, both populations were able to present,
with similar efficiencies, the OVA peptide (Fig. 8 c).
The Ability of DC to Produce IL-12 p75 Correlates with its
Functional Maturation. Bioactive IL-12 p75 is the regula-
tory cytokine which drives the development of Th1 cells
and promotes cell-mediated immunity. IL-12 p75 produc-
tion by TNFa-treated or untreated D1 cells was measured
in a presentation assay in the presence of OVA-specific T cell
hybridoma (BO97.9). Immature D1 cells fail to produce
IL-12 p75 constitutively or upon stimulation with heat-
treated S. aureus and IFNg (data not shown) or in the pres-
ence of the BO97.10 hybridoma (Fig. 9). In contrast, IL-12
p75 secretion was readily detectable in TNFa-matured D1
cells after interaction with antigen-specific T cell hybri-
doma. This result indicates that the feedback between T cells
and DC is mediated by TCR-peptide/class II interaction.
In order to exert this property, DC need to reach a stage of
functional maturation which is not met by immature DC.
Discussion
DC originating from bone marrow cells, which include
CFU-DC that yield homogeneous DC colonies under par-
ticular cytokine conditions (23), enter the blood as progen-
itors and colonize, from the blood stream, lymphoid, and
non-lymphoid tissues. Spleen DC were identified for the
first time by Steinman in 1979 (24) and were shown to be
the predominant stimulators in the MLR reaction (25). In
spite of two decades of studies, the DC differentiation pro-
cess remains an unsolved issue and many key questions are
still under investigation. Are DC progenitors predeter-
mined to differentiate into fully mature DC and is this
commitment irreversible? What are the functions that cor-
relate with the various DC differentiation stages? To ad-
dress some of these questions, the differentiation potential
of immature spleen DC was investigated with the purpose
to reproduce in vitro the process of DC differentiation and
define the checkpoints of the so-called DC maturation.
We established an homogeneous immature DC popula-
tion driven to proliferate for as long as growth factors are
provided. These long-term, growth factor–dependent im-
mature DC cells could be induced to mature in vitro, upon
activation with a number of regulatory signals, into termi-
nally differentiated DC. Using this defined model system,
we identified three sequential stages of the DC maturation:
stage 1 is adherent and characterized by a high proliferation
rate, a low motility, and a highly organized cytoskeleton.
The expression of MHC class II molecules seems to be
mainly restricted to cytoplasmic vesicles positive for H2-Mb
Figure 8. Allostimulatory and
processing capacities of D1 cells.
(a) Mixed lymphocyte reaction
(MLR) by sorted I-Abright and
I-Aint D1 cells shows that the
mature I-Abright cells are the ones
that have the highest allostimula-
tory capacity. Presentation of the
OVA protein is downregulated
by TNFa treatment. Antigen-
specific presentation of exoge-
nous OVA protein (b) or OVA-
peptide327-339 ( c ) by D1 cells
treated or not with TNFa for 1
or 7 d: presentation of the OVA
peptide is not affected by matu-
ration but presentation of the
OVA protein is downregulated
by TNFa.
Figure 9. IL-12 p75 production by D1 cells pretreated or not with
TNFa upon presentation of OVA protein to the specific hybridoma
BO97.10 (striped bars or in the absence of the hybridoma open bars). IL-12
p75 was measured using an ELISA as described in Material and Methods.
Il-12 p75 was quantified from two to three titration points using standard
curves generated by purified recombinant mouse IL-12 and results ex-
pressed as cytokine concentration in pg/ml. Detection limit was 10 pg/ml.326 Maturational Stages of Mouse Dendritic Cells
molecules thus indicating that the majority of the class II
molecules are located in a compartment similar to the
MHC. CD40 and B7.2 costimulatory molecules are ex-
pressed at low level. Furthermore, these immature DC are
inefficient in allostimulatory activity and are unable to se-
crete IL-12 but have a high capacity of antigen uptake and
processing.
Progression from stage 1 towards stage 2 requires signal-
ing, and this can be achieved using living bacteria, LPS or
cytokines such as TNFa or IL-1b but not IL-6. Stage 2,
which is induced in few hours and is completed after one
day, is characterized by low proliferative rate, high motil-
ity, and complete depolarization of actin cytoskeleton with
loss of adhesiveness. In addition, mature DC rearrange the
cell surface expression of receptors and molecules: MHC
class II, CD-40, and B7.2 molecules become highly ex-
pressed on the cell surface and this may correlate with the
ability to produce IL-12.
Interestingly, intracellular class II–containing compart-
ments appear to be different from the ones observed in im-
mature D1 cells, given that colocalization with the H2-Mb
molecule is no longer detectable. In contrast, mature DC
disassemble actin-based cytoskeleton, lose adhesion plaques,
and become inefficient in protein antigen uptake and pre-
sentation. However, allostimulatory activity and peptide
presentation remain very efficient.
Most of these cells will spontaneously progress towards
stage 3 where they completely stop proliferation. In agree-
ment with this hypothesis we also found that MHC class
IIhigh sorted D1 cells, if recultured after sorting, enter stage 3,
characterized by cell growth arrest and final cell death by
apoptosis. In contrast, sorting and reculture of the MHC
class IIint D1 subpopulation leads to the development of a
population which resembles the initial bulk D1 cells. Thus,
the D1 bulk population contains self-renewal progenitors
from which both immature and mature DC can be easily
generated.
All the stages of this sequential maturation are relevant
for experimental therapeutics and transplantation biology.
In fact, the growth of heterogeneous bulk DC populations
or selected immature DC, may be more suitable for exper-
imental therapeutics than the growth of selected fully ma-
ture DC undergoing terminal differentiation. We have shown
that native proteins are better presented by immature DC
whereas peptides are better presented by mature DC. There-
fore, design of therapeutical approaches based either on
protein or peptide DC loading should carefully consider
the stage of DC maturation; to select the most suitable DC
subpopulation the purification procedures should be well
defined as well as the culture conditions in order to pre-
serve either immature or mature DC. Which factors pre-
serve the self-renewal potential of the progenitors and what
prevents the full maturation of the D1 cells (in the culture
conditions described above) are still open questions, pres-
ently under investigation.
Our data concerning the process of DC maturation are
in agreement with a number of studies (2, 3, 5, 9, 10, 13,
23, 26) but are in contrast with some others. In particular,
the current view of a full interconversion between mature
DC and macrophages (27) should be carefully examined at
the single cell level using homogeneous cell populations,
such as the D1 cells. The DC phenotype could not be re-
versed into a macrophage one, indicating that once the
bulk DC population is committed to the DC phenotype
this process is irreversible. When the purification proce-
dures can not separate shared precursors (likely to be in
common with monocytes) the lineage commitment is
more difficult to be observed.
What stimuli induce full differentiation of mouse DC? In
this study we provide the first evidence that TNFa plays a
crucial role in mouse DC maturation, as previously re-
ported in human monocyte-derived (13) and bone mar-
row–derived DC (23), as well as in LC (7). We also
showed that IL-1b induces phenotypical DC maturation,
most likely through a paracrine induction of TNFa expres-
sion, as shown in LC (6, 28, 29). Living bacteria and bacte-
rial cell constituents are also strong inducers of full DC
maturation, including upregulation of the costimulatory mole-
cules B7.2 and CD40. It is likely that in vivo, the first sig-
nals inducing DC maturation are delivered by microbes
since we previously showed a paracrine induction of TNFa
expression in DC infected with Gram1 and Gram2 bacteria
(30). Thus, TNFa is most likely a signal 2 for sequential
DC maturation, whereas pathogens represent a signal 1.
In addition to its function in DC morphological matura-
tion, TNFa also promotes DC emigration (4) from tissues
such as skin, intestine, heart, and kidney (4, 29, 31, 32).
The non-lymphoid DC need to move on to the regional
lymph nodes in order to encounter naive T cells and elicit
primary immune responses. Thus, the migratory properties
are an essential component of the DC function. In this re-
port we also provide the first evidence that TNFa is able to
induce a complete rearrangement of the actin-based cy-
toskeleton in DC.
This actin disassembly could explain the decreased mac-
ropinocytosis ability of mature DC as proposed in other
systems (33). The disassembly of actin filaments upon TNFa
treatment is correlated with a loss of endocytic capacity in
DC. Macropinocytosis represents one of the most efficient
antigen uptake mechanism in DC but requires the integrity
of polymerized actin filaments; it is likely that DC matura-
tion shuts off the micropynocytic pathway by inducing ac-
tin disassembly. The modification of the actin cytoskeleton
is also relevant in the acquisition of migration properties of
mature DC. TNFa treatment induces cell detachment and
formation of an organized centriolar array of microtubules
which are likely to be highly dynamic (34). Membrane ex-
pansions of mature DC, which occur in response to the
cytoskeleton remodeling, also appear highly dynamic: vin-
culin containing adhesive structures disappear and the cells
acquire migratory properties. By time-lapse videomicros-
copy we were able to show the highly enhanced motility of
the TNFa-activated D1 cells. Because F-actin seems to be
mainly disorganized, whereas microtubules are still highly
organized, our data indicate a role for microtubules in de-
termining DC movements. In vivo, motility should unable327 Winzler et al.
DC to encounter T cells and the final outcome should be
T cell activation and Th1/Th2 polarization. It has been
proposed that DC maturation continues until DC-T cell
interaction occurs (35) but in the D1 model mature DC
were driven to terminal differentiation even in the absence
of T cells. On the other hand, interaction of DC with T cells
was essential for IL-12 production (this study and 36). In-
terestingly, immature DC fail to produce IL-12 p75 either
upon stimulation with heat treated S. aureus and IFNg or
after activation with antigen-specific T cell hybridoma. In
contrast, IL-12 p75 secretion is readily detectable in TNFa-
treated DC after interaction with antigen-specific T cells.
This result indicates that the feedback between T cells and
DC is dependent on TCR-peptide/class II interaction and
this property is reached at stage 2 of functional maturation.
These data also indicate that DC may play a major role in
polarizing the immune response towards the Th1 pathway.
The model system analyzed in this study reproduces DC
differentiation in vitro from the very early events towards
terminal maturation. A fine molecular analysis of each step
of functional DC maturation can now be undertaken.
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